Not a good buy right now for an impatient entry: price is extended (RSI extremely overbought) and trading into/above a key resistance zone, increasing near-term pullback risk.
Options flow is mixed-to-cautious short-term (put volume > call volume), which typically does not support chasing a breakout at the open.
If you already own it, the trend is bullish; if you don’t, the data favors waiting for a pullback toward support rather than buying immediately.
Technical Analysis
Trend: Bullish (SMA_5 > SMA_20 > SMA_200) with positive momentum.
MACD: Histogram +0.324 and expanding → confirms upside momentum.
RSI (6): 89.322 → extremely overbought, often followed by mean reversion.
Key levels: Pivot 71.027; Resistance R2 74.166 (pre-market ~74.42 is at/above R2); Support S1 69.086.
Pattern-based forward view: ~50% odds of -1.28% next day; +0.44% next week; +1.57% next month → suggests upside is more gradual and not necessarily immediate after an overbought spike.
Options Data
Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio
Positioning (Open Interest PCR 0.63): More call OI than put OI → medium-term tilt bullish.
Today’s flow (Volume PCR 1.5): Put volume heavier than call volume → near-term caution/hedging.
Activity: Volume ~125.6% of 30-day average → elevated attention; can accompany reversals near resistance.
Volatility: IV30 ~20.95 vs HV ~18.11 (modest premium); IV percentile 42 / IV rank ~21 → volatility not “cheap,” but not extreme.
Wall Street cons: structural headwinds in beverages category and skepticism about sustained growth (reflected in DB downgrade and lower targets).
Wall Street analysts forecast BUD stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BUD is 75 USD with a low forecast of 75 USD and a high forecast of 75 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Analyst Rating
Wall Street analysts forecast BUD stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BUD is 75 USD with a low forecast of 75 USD and a high forecast of 75 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 74.990
Low
75
Averages
75
High
75
Current: 74.990
Low
75
Averages
75
High
75
Barclays
Overweight
maintain
AI Analysis
2025-12-11
Reason
Barclays
Price Target
AI Analysis
2025-12-11
maintain
Overweight
Reason
Barclays raised the firm's price target on AB InBev to EUR 94 from EUR 88 and keeps an Overweight rating on the shares. The firm believes growth of ride-hailing and robotaxi services in the United States could boost alcohol sales. The impact has the potential to be significant and come sooner than the market anticipates, the analyst tells investors in a research note.
Morgan Stanley
Overweight
to
NULL
downgrade
2025-12-08
Reason
Morgan Stanley
Price Target
2025-12-08
downgrade
Overweight
to
NULL
Reason
Morgan Stanley lowered the firm's price target on AB InBev to EUR 66.50 from EUR 68 and keeps an Overweight rating on the shares.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for BUD
